GREY:VERS (USA) Also Trade In: UK
Verseon Corp $ 0.03 0 (0%)
Warning! GuruFocus has detected with VERS. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for VERS (Verseon Corp) from 2016 to Nov 27 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Verseon stock (VERS) PE ratio as of Nov 27 2020 is 0. More Details
Verseon PE Ratio (TTM) Historical Data
View and export this data going back to 2016. Start your Free Trial
Verseon PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare ASX:NEU TSX:RVX WAR:SLV NAS:VKTX TSX:NEPT TSX:VBV NAS:ARQL XKRX:060590 NAS:ADMA XKRX:142760 NAS:TYME XPAR:TNG XBRU:MDXH NAS:SCPH NAS:KIN XKRX:196170 OCSE:ORPHA LSE:IMM BOM:531349 NAS:VTL
Address 47071 Bayside Parkway, Fremont, CA, USA, 94538
Verseon Corp is a part of the healthcare sector in the United States. It is a technology-based pharmaceutical company with a computer-driven drug discovery platform. The company designs novel drug candidates that are unlikely to be found using conventional methods. It is also engaged in drug discovery programs such as the diabetic macular edema product candidates, which treat the diseases by controlled disruption of the kallikrein kinin cascade.